spacer
home > ebr > spring 2002 > donation of organs and tissues - new legislation in finland on the prerequisites for medical research
PUBLICATIONS
European Biopharmaceutical Review

Donation of Organs and Tissues - New Legislation in Finland on the Prerequisites for Medical Research

The protection of and right to human organs, tissues and genomics in medical research is an increasingly discussed topic and it gives rise not only to reforms of legislation but also to ethical debate. The ratification of the Convention of Human Rights and Biomedicine (1) in 1997 required some changes to the then existing legislation in Finland, but at the same time it was considered necessary to reform the legislation on human organs and tissues in medical research as a whole. In addition, other international conventions, such as the United Nations Convention on Civil and Political Rights (2), put pressure on the national legislation of human organs and tissues in medical research.The most recent considerable reform in Finland in relation to biosciences law was the introduction of the Act on Medical Use of Human Organs and Tissues in 2001. The new legislation will certainly influence the future of the medical use of human organs and tissues in Finland, both from a contractual and a practical point of view.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Rainer Hilli, Partner, and Liisa Laurila, Lawyer, at Roschier Holmberg, Attorneys Ltd

Rainer Hilli is a Partner at Roschier Holmberg and is responsible for the company's technology, media and competition group, specialising mainly in matters relating to copyright, patents, trademarks, designs, computer law, telecommunications law, media law, market law and the life sciences.
Rainer's experience includes multi-jurisdictional IP litigation and IP-driven acquisitions. He is a frequent speaker and writer of articles in the field of intellectual property.
Liisa Laurila, MSc (Econ), LLM, works as a Lawyer for Roschier Holmberg in the technology, media and competition practice group. Liisa is a member of the firm's pharmaceutical and biosciences specialist team.
She advises on copyright and trademarks as well as on general corporate matters. Liisa specialises in data protection and life sciences law, and her working languages are Finnish, Swedish and English.

spacer
Rainer Hilli
spacer
spacer
spacer
Liisa Laurila
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Virtual Visit Capabilities Keep Clinical Trials on Track during COVID-19

ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a Virtual Visit solution that enables the continuation of clinical trials during and after current global stay-at-home mandates. As a result of COVID-19, many clinical trials have been delayed as healthcare providers focus their efforts on patients who require urgent care, which limits clinical trial patientsí access to investigative sites for routine visits.
More info >>

White Papers

Clinical Research in Spain

BioClever

This whitepaper is on clinical research in Spain, giving a general outline of the main characteristics of research in this country and an overview of the applicable regulations, along with the reasons why Spain is a good place to do research.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement